Ventyx Biosciences
Matthew Moore serves as Chief Operating Officer at Ventyx Biosciences and previously held the position of Chief Business Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT). Prior experience includes serving as Vice President of Corporate Business Development at Allergan and as Executive Director of Business Development at Allergan, formerly Actavis. Matthew Moore brings extensive experience in business development and corporate strategy within the biopharmaceutical industry.
This person is not in any teams
This person is not in any offices
Ventyx Biosciences
1 followers
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.